Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
4.060
-0.350 (-7.94%)
At close: Oct 31, 2024, 4:00 PM
4.170
+0.110 (2.71%)
After-hours: Oct 31, 2024, 4:16 PM EDT
Telomir Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Selling, General & Admin | 4.26 | 2.37 | 0.02 | 0.01 |
Research & Development | 1.87 | 1.57 | 0.83 | 0.13 |
Operating Expenses | 6.12 | 3.94 | 0.85 | 0.14 |
Operating Income | -5.42 | -3.94 | -0.85 | -0.14 |
Interest Expense | -5.86 | -1.64 | - | - |
EBT Excluding Unusual Items | -11.26 | -5.59 | -0.85 | -0.14 |
Other Unusual Items | -7.49 | -7.49 | - | - |
Pretax Income | -18.74 | -13.07 | -0.85 | -0.14 |
Net Income | -18.74 | -13.07 | -0.85 | -0.14 |
Net Income to Common | -18.74 | -13.07 | -0.85 | -0.14 |
Shares Outstanding (Basic) | 29 | 27 | 27 | - |
Shares Outstanding (Diluted) | 29 | 27 | 27 | - |
Shares Change (YoY) | 5.23% | 1.77% | - | - |
EPS (Basic) | -0.66 | -0.48 | -0.03 | - |
EPS (Diluted) | -0.66 | -0.48 | -0.03 | - |
Free Cash Flow | -6.55 | -3.86 | -0.47 | -0.12 |
Free Cash Flow Per Share | -0.23 | -0.14 | -0.02 | - |
EBIT | -5.42 | -3.94 | -0.85 | -0.14 |
Source: S&P Capital IQ. Standard template.
Financial Sources.